Literature DB >> 11873259

[Schistosoma mansoni: the action of lovastatin on the murine model].

Neusa Araujo1, Anna Kohn, Aureo Almeida de Oliveira, Naftale Katz.   

Abstract

Aimed to evaluate the lovastatin action on Schistosoma mansoni oviposition, infected mice with 100 plus minus 10 cercariae of the LE strain were used. Thirty days after infection the animals were treated with 100, 200 and 400mg/kg of lovastatin, per os, during five consecutive days and then sacrificed 7, 15, 30 or 60 days after treatment. We analyzed: distribution of worms in mesenteries and liver; mortality of worms in the liver; alteration of the oogram; eggs counting in the jejunum and liver; presence of intrauterine eggs and morphology of the worms from the treated and control groups (infected and not treated animals). Significant statistical differences were found between treated and control groups when the presence of intrauterine eggs was considered and also, alteration on the oogram, eggs at different stages of development in jejunum, liver and in the body length of males and females. The morphological study of the worms showed that the degenerative modifications occurred, mainly in the reproductive system, with reduction and alteration of the viteline follicles and the ovary of the females. Also modifications in the males testicles were observed. The results suggest that the drug under study reduces, considerably, the female S. mansoni, oviposition increases the worms' size, leads to alteration in the reproductive system of males and females. It also may induce death of a significant part of the worm populations at the dose of 400mg/kg.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873259     DOI: 10.1590/s0037-86822002000100007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  4 in total

1.  A new description of the reproductive system of Schistosoma mansoni (Trematoda: Schistosomatidae) analyzed by confocal laser scanning microscopy.

Authors:  Renata Heisler Neves; Carla de Lamare Biolchini; José Roberto Machado-Silva; Jorge José Carvalho; Thiago Braga Branquinho; Henrique Leonel Lenzi; Maarten Hulstijn; Delir Corrêa Gomes
Journal:  Parasitol Res       Date:  2004-11-25       Impact factor: 2.289

2.  Anthelmintic activity of carvacryl acetate against Schistosoma mansoni.

Authors:  Josué de Moraes; Aline A Leite Carvalho; Eliana Nakano; Antonia Amanda Cardoso de Almeida; Thiago Henrique da Costa Marques; Luciana Nalone Andrade; Rivelilson Mendes de Freitas; Damião Pergentino de Sousa
Journal:  Parasitol Res       Date:  2012-10-21       Impact factor: 2.289

3.  Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis.

Authors:  Liliana Rojo-Arreola; Thavy Long; Dan Asarnow; Brian M Suzuki; Rahul Singh; Conor R Caffrey
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

4.  Identification of anti-schistosomal, anthelmintic and anti-parasitic compounds curated and text-mined from the scientific literature.

Authors:  Avril Coghlan; Gilda Padalino; Noel M O'Boyle; Karl F Hoffmann; Matthew Berriman
Journal:  Wellcome Open Res       Date:  2022-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.